Biomarker guided therapy clinical trials

Medico-economic Evaluation of Therapeutic Adaptation Guided by the Soluble Suppression of Tumorigenicity 2 (sST-2) Biomarker in the Management of Patients With Acute Heart Failure

This study looks at whether monitoring a special blood test called sST2 can help improve the care of people with heart failure. We want to see if using this test helps reduce hospital stays and improves quality of life for patients.